InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+18.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by OLDAKOWSKI MARK, Chief Executive Officer. Insider active across 3 companies, notably Bionano Genomics, Inc. Cumulatively, 11 disclosures have been logged. Activity tracked since 12 May 2021. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
27 shares@ US$1.300.0002% mcap0.0% of flowCommon StockSEC:0001745566-26-000006:0
20 shares@ US$5.730.1% of flowCommon StockSEC:0001411690-25-000019:0
3,568 shares@ US$0.481.8% of flowCommon StockSEC:0001411690-24-000053:0
16,000 shares0Common StockSEC:0001415889-24-015624:0
1,229 shares@ US$1.271.7% of flowCommon StockSEC:0001415889-24-006810:0
20,000 shares0Common StockSEC:0001209191-23-050186:0
41,496 shares@ US$0.6629.7% of flowCommon StockSEC:0001411690-23-000030:0
120,000 shares0Common StockSEC:0001209191-23-010920:0
41,496 shares@ US$1.410.34% mcap100.0% of flowCommon StockSEC:0001209191-22-029458:0
240,000 shares0Common StockSEC:0001209191-21-032932
240,000 shares0Common StockSEC:0001209191-21-032932:0
11 of 11 declarations
About OLDAKOWSKI MARK
OLDAKOWSKI MARK serves as Chief Operating Officer at Bionano Genomics, Inc. He oversees the daily operations of the company, ensuring that processes are efficient and aligned with strategic goals. His experience in operational management is crucial for the development and growth of the organization.
